It’s time to recognise pharmacy excellence
Past PSA Excellence Award winners share what the recognition meant to them and the professional doors it can open.
Uniting pharmacists and doctors for patient safety
Responsibility for providing the highest level of patient care and safety as possible rests with no single healthcare provider. The best results will always...
Update on breast cancer risk with HRT
Hormone replacement therapy may pose a risk to the development of breast cancer, according to new research.
The incidence of breast cancer is higher in...
PSA’s up-to-date COVID-19 advice for pharmacists
As the number of COVID-19 cases continues to rise in Australia, PSA is working to ensure pharmacists’ needs are considered in pandemic planning.
Will a repurposed drug help treat COVID-19?
There are 344 registered interventional clinical trials under way for the treatment and prevention of COVID-19. The WHO is looking at four of them.
NIP access (almost) guaranteed
The state's major parties have committed to allowing pharmacist immunisers to access the National Immunisation Program (NIP) for the first time.